Sonoma Pharmaceuticals Inc
NASDAQCM:SNOA
United States / Healthcare / Pharmaceuticals
SNOA News
Welcome to Your News Upgrade
Be the First to Know and Act on Market Moving News.
Sonoma Pharmaceuticals expands agreement with WellSpring
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a developer of medical products showing strong momentum with a 20% year-to-date return, has expanded its partnership with WellSpring ...
Sonoma Pharmaceuticals expands into UK market
BOULDER, CO - Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare company, announced today that its manufacturing facility and five of its products have been officially...
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by MHRA
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products...
SNOA stock touches 52-week low at $2 amid market challenges
In a year marked by significant volatility, Sonoma Pharmaceuticals, Inc. (SNOA) stock has reached a new 52-week low, dipping to the $2.00 threshold. According to InvestingPro data,...
SNOA Stock Touches 52-Week Low at $2.29 Amid Market Challenges
In a challenging market environment, shares of Sonoma Pharmaceuticals, Inc. (SNOA) have reached a 52-week low, dipping to $2.29. According to InvestingPro data, the company...
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology...
SNOA stock touches 52-week low at $2.44 amid market challenges
In a challenging market environment, shares of Sonoma Pharmaceuticals, Inc. (SNOA) have reached a 52-week low, dipping to $2.44. According to InvestingPro analysis, the stock...
Sonoma Pharmaceuticals secures new supply agreement
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a specialist in surgical and medical instruments with annual revenues of $13.55 million, has entered into a significant agreement with...
Sonoma Pharmaceuticals announces executive equity grants
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a medical instruments and apparatus company with a market capitalization of $3.56 million, disclosed on Thursday the completion of its...
SNOA stock touches 52-week low at $2.44 amid market challenges
In a challenging market environment, shares of Sonoma Pharmaceuticals, Inc. (SNOA) have reached a 52-week low, dipping to $2.44. With a market capitalization of just $3.33 million...